Загрузка...
The effect of abaloparatide-SC on fracture risk is independent of baseline FRAX fracture probability: a post hoc analysis of the ACTIVE study
Daily subcutaneous (SC) injections of the investigational drug abaloparatide-SC (80mcg) for 18 months significantly decrease the risk of vertebral and non-vertebral fracture compared with placebo in postmenopausal women. We examined the efficacy of abaloparatide-SC as a function of baseline fracture...
Сохранить в:
| Опубликовано в: : | J Bone Miner Res |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5553106/ https://ncbi.nlm.nih.gov/pubmed/28474780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.3163 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|